These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 17926832

  • 1. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
    Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
    [Abstract] [Full Text] [Related]

  • 2. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
    Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF.
    Gastroenterology; 2009 Oct; 137(4):1250-60; quiz 1520. PubMed ID: 19596014
    [Abstract] [Full Text] [Related]

  • 3. A review of infliximab use in ulcerative colitis.
    Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [Abstract] [Full Text] [Related]

  • 4. Is keeping the colon the ultimate marker of success in ulcerative colitis?
    Nguyen GC, Prather CM.
    Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125
    [No Abstract] [Full Text] [Related]

  • 5. Infliximab therapy for ulcerative colitis: many unanswered questions.
    Present DH.
    Am J Gastroenterol; 2001 Aug; 96(8):2294-6. PubMed ID: 11513164
    [No Abstract] [Full Text] [Related]

  • 6. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A.
    Eur Rev Med Pharmacol Sci; 2004 Aug; 8(5):231-3. PubMed ID: 15638236
    [Abstract] [Full Text] [Related]

  • 7. Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
    Chaparro M, Panes J, García V, Mañosa M, Esteve M, Merino O, Andreu M, Gutierrez A, Gomollón F, Cabriada JL, Montoro MA, Mendoza JL, Nos P, Gisbert JP.
    J Clin Gastroenterol; 2011 Feb; 45(2):113-8. PubMed ID: 21242747
    [Abstract] [Full Text] [Related]

  • 8. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
    Clare DF, Alexander FC, Mike S, Dan G, Allan F, Lisa W, Peter HJ.
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
    [Abstract] [Full Text] [Related]

  • 9. Infliximab in ulcerative colitis.
    Aberra FN, Lichtenstein GR.
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [Abstract] [Full Text] [Related]

  • 10. Infliximab for the treatment of ulcerative colitis.
    Eshuis EJ, Bemelman WA, Stokkers PC.
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804
    [Abstract] [Full Text] [Related]

  • 11. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK, Uzcanga LF.
    Dig Surg; 2008 Jun; 25(5):383-6. PubMed ID: 19005257
    [Abstract] [Full Text] [Related]

  • 12. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R.
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [Abstract] [Full Text] [Related]

  • 13. Guidelines for treatment with infliximab for Crohn's disease.
    Hommes DW, Oldenburg B, van Bodegraven AA, van Hogezand RA, de Jong DJ, Romberg-Camps MJ, van der Woude J, Dijkstra G, Dutch Initiative on Crohn and Colitis (ICC).
    Neth J Med; 2006 Oct; 64(7):219-29. PubMed ID: 16929083
    [Abstract] [Full Text] [Related]

  • 14. Is infliximab effective for induction of remission in patients with ulcerative colitis?
    Lichtenstein GR.
    Inflamm Bowel Dis; 2001 May; 7(2):89-93. PubMed ID: 11383596
    [No Abstract] [Full Text] [Related]

  • 15. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
    Rutgeerts P, Van Assche G, Vermeire S.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):451-63. PubMed ID: 16441465
    [Abstract] [Full Text] [Related]

  • 16. [Inflammatory diseases of the intestines].
    Felley C, Guyot J, Hess J, Mottet C, Delarive J, Michetti P.
    Rev Med Suisse; 2006 Jan 18; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
    [Abstract] [Full Text] [Related]

  • 17. Timing infliximab therapy in pediatric Crohn's disease.
    Kirschner BS, Huo D.
    Gastroenterology; 2007 Mar 18; 132(3):1167-70. PubMed ID: 17383435
    [No Abstract] [Full Text] [Related]

  • 18. [Biological therapy as treatment of inflammatory bowel diseases].
    Agnholt J.
    Ugeskr Laeger; 2008 Jun 09; 170(24):2152-6. PubMed ID: 18565302
    [Abstract] [Full Text] [Related]

  • 19. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
    Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ.
    Gastroenterology; 2011 Oct 09; 141(4):1194-201. PubMed ID: 21723220
    [Abstract] [Full Text] [Related]

  • 20. Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study.
    Jahnsen J, Detlie TE, Vatn S, Ricanek P.
    Expert Rev Gastroenterol Hepatol; 2015 Oct 09; 9 Suppl 1():45-52. PubMed ID: 26395534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.